Skip to main content
OpenTrials

Clinical trial condition

Pancreatic Ductal Adenocarcinoma (PDAC)

Explore clinical trials studying Pancreatic Ductal Adenocarcinoma (PDAC). Study availability and eligibility vary by location and protocol.

76 public trials 45 recruiting studies
Refine in advanced search Browse all conditions

Pancreatic Ductal Adenocarcinoma (PDAC) trial results

Recruiting

Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

NCT07562152

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +17 more
Locations
  • City of Hope Phoenix, Arizona, United States
  • City of Hope Duarte, California, United States
  • Medical Oncology Hematology Consultants Newark, Delaware, United States
  • Hematology Oncology Associates of the Treasure Coast Port Saint Lucie, Florida, United States
View all 51 locations
View Trial Details
Recruiting

A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)

NCT07450859

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +10 more
Locations
  • Siteman Cancer Center (Washington University School of Medicine) St Louis, Missouri, United States
  • Memorial Sloan Kettering Cancer Center - Main Campus New York, United States
  • Thomas Jefferson University, Sidney Kimmel Comprensive Cancer Center, Clinical Trials Office Philadelphia, Pennsylvania, United States
  • Mayo Clinic Arizona Phoenix, Arizona, United States
View Trial Details
Recruiting

Study of BPI-572270 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

NCT07435038

Conditions
Advanced Solid Tumors, Bronchial Neoplasms, Carcinoma, Bronchogenic, +20 more
Locations
  • Blacktown Hospital Blacktown, New South Wales, Australia
  • Scientia Clinical Research Randwick, New South Wales, Australia
  • GenesisCare St Leonards, 7 Westbourne St, St Leonards Sydney, New South Wales, Australia
  • Southern Oncology Clinical Research Unit (SOCRU) Bedford Park, South Australia, Australia
View Trial Details
Recruiting

Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors

NCT07349537

Conditions
Advanced Solid Tumors, Bronchial Neoplasms, CRC, +30 more
Locations
  • Yale Cancer Center New Haven, Connecticut, United States
  • Johns Hopkins Baltimore, Maryland, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • START Midwest Grand Rapids, Michigan, United States
View Trial Details
Recruiting

Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Pancreatic Ductal Adenocarcinoma (PDAC)

NCT07217717

Conditions
Pancreatic Ductal Adenocarcinoma (PDAC)
Locations
  • Helios CR Inc./RadNet Cerritos, California, United States
  • City of Hope National Cancer Center Duarte, California, United States
  • Hoag Memorial Hospital Irvine, California, United States
  • UCLA Los Angeles, California, United States
View all 16 locations
View Trial Details
Recruiting

[68Ga]BED003 PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications

NCT07702292

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Diseases, +39 more
Locations
  • Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII Bergamo, Lombardy, Italy
  • Fondazione IRCCS San Gerardo dei Tintori Monza, Lombardy, Italy
  • Fondazione Policlinico Universitario A. Gemelli IRCCS - Universita Cattolica del Sacro Cuore Roma, Italy
  • IRCCS Ospedale San Raffaele Milan, Segrate, Italy
View Trial Details
Recruiting

Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

NCT07491445

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +13 more
Locations
  • Honor Health Research Institute Scottsdale, Arizona, United States
  • H Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View all 49 locations
View Trial Details
Recruiting

Breath Research Narrow Validation for Gastrointestinal Cancer Detection

NCT07714538

Conditions
Adenocarcinoma, Adenocarcinoma Of Esophagus, Carcinoma, +35 more
Locations
  • Maidstone and Tunbridge Wells NHS Trust Maidstone, Kent, United Kingdom
  • Liverpool University Hospitals NHS Foundation Trust Liverpool, Merseyside, United Kingdom
  • NHS Greater Glasgow and Clyde Glasgow, United Kingdom
  • The Clatterbridge Cancer Centre NHS Foundation Trust Liverpool, United Kingdom
View Trial Details
Recruiting

Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )

NCT07621718

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +13 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Piedmont Healthcare Atlanta, Georgia, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
  • Johns Hopkins University Baltimore, Maryland, United States
View Trial Details

Related conditions